Diane D Davey

Summary

Affiliation: University of Kentucky
Country: USA

Publications

  1. ncbi Human papillomavirus testing--are you ready for a new era in cervical cancer screening?
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington 40536 0298, USA
    Arch Pathol Lab Med 127:927-9. 2003
  2. ncbi Cytopathology update on atypical squamous cells
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 0298, USA
    J Low Genit Tract Dis 9:124-9. 2005
  3. ncbi Cervical cytology classification and the Bethesda System
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 0298, USA
    Cancer J 9:327-34. 2003
  4. ncbi Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington 40526 0298, USA
    Arch Pathol Lab Med 128:1224-9. 2004
  5. ncbi ASC-US and HPV testing in women aged 40 years and over
    Kathy S Bruner
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA
    Diagn Cytopathol 31:358-61. 2004
  6. ncbi Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Amy L Cooper
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536 0298, USA
    Obstet Gynecol 107:71-6. 2006
  7. ncbi Accuracy of Thinprep Imaging System in detecting atypical glandular cells
    Yasodah Jayamohan
    Department of Pathology and Laboratory Medicine, Chandler Medical Center, University of Kentucky, Lexington, Kentucky 40536, USA
    Diagn Cytopathol 37:479-82. 2009
  8. ncbi ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, USA
    Am J Clin Pathol 118:714-8. 2002
  9. ncbi Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts?
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, Fla, USA
    Arch Pathol Lab Med 129:609-13. 2005
  10. ncbi Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital, Miami, Fla, USA
    Arch Pathol Lab Med 128:153-7. 2004

Collaborators

Detail Information

Publications20

  1. ncbi Human papillomavirus testing--are you ready for a new era in cervical cancer screening?
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington 40536 0298, USA
    Arch Pathol Lab Med 127:927-9. 2003
  2. ncbi Cytopathology update on atypical squamous cells
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 0298, USA
    J Low Genit Tract Dis 9:124-9. 2005
    ..Women with ASCUS may be managed by human papillomavirus DNA testing, repeated cytology, or colposcopy, while women with ASC-H should generally proceed to colposcopy...
  3. ncbi Cervical cytology classification and the Bethesda System
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536 0298, USA
    Cancer J 9:327-34. 2003
    ..Other changes are discussed, and a brief update of cancer screening guidelines is also provided...
  4. ncbi Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington 40526 0298, USA
    Arch Pathol Lab Med 128:1224-9. 2004
    ..The 2001 Bethesda System for the reporting of cervical cytology specimens and the use of new liquid-based and human papillomavirus testing technologies have led to changes in cervical cytology reporting practices...
  5. ncbi ASC-US and HPV testing in women aged 40 years and over
    Kathy S Bruner
    Department of Pathology and Laboratory Medicine, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA
    Diagn Cytopathol 31:358-61. 2004
    ..Therefore, additional clinician education and reminders to correlate cytology and HPV test results may be warranted to optimize patient care...
  6. ncbi Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Amy L Cooper
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536 0298, USA
    Obstet Gynecol 107:71-6. 2006
    ..The study objective was to assess the efficacy and costs associated with Pap tests in routine surveillance of women with uterine cancer...
  7. ncbi Accuracy of Thinprep Imaging System in detecting atypical glandular cells
    Yasodah Jayamohan
    Department of Pathology and Laboratory Medicine, Chandler Medical Center, University of Kentucky, Lexington, Kentucky 40536, USA
    Diagn Cytopathol 37:479-82. 2009
    ..However, full manual review of cases with potential atypical/reactive groups or endometrial groups in women > or = 40 and QC rescreening of selected cases may help to minimize the underdetected cases...
  8. ncbi ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators
    Diane D Davey
    Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, USA
    Am J Clin Pathol 118:714-8. 2002
    ..The management guidelines will help promote optimal and uniform follow-up of women according to Pap test specimen adequacy...
  9. ncbi Measuring the significance of field validation in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology: how good are the experts?
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital of Miami, Miami, Fla, USA
    Arch Pathol Lab Med 129:609-13. 2005
    ..However, the reliability of expert opinion alone in selecting slides of a specific cytodiagnosis that can be reproducibly and reliably identified by subsequent reviewers has not been determined...
  10. ncbi Detection of adenocarcinoma in situ of the cervix in Papanicolaou tests: comparison of diagnostic accuracy with other high-grade lesions
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital, Miami, Fla, USA
    Arch Pathol Lab Med 128:153-7. 2004
    ..CONCLUSION: These data from expert-referenced and biopsy-proven cases suggest that adenocarcinoma in situ is not as easily recognized or categorized as other serious diagnoses...
  11. ncbi Precision in gynecologic cytologic interpretation: a study from the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology
    Andrew A Renshaw
    Department of Pathology, Baptist Hospital, Miami, Fla, USA
    Arch Pathol Lab Med 127:1413-20. 2003
    ..Cytologic interpretations of LSIL are made with greater precision than those of HSIL and may represent a more appropriate endpoint to measure the precision performance of gynecologic cytology laboratories...
  12. ncbi Reflex human papillomavirus testing: leave the cytology interpretation alone
    Diane D Davey
    Cancer 99:187-90. 2003
  13. ncbi The new era of cervical cancer prevention: the end of the Pap smear?
    Diane D Davey
    Diagn Cytopathol 28:289-90. 2003
  14. ncbi Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program
    Andrew A Renshaw
    College of American Pathologists Gynecologic Cytology Program, Northfield, Ill, USA
    Arch Pathol Lab Med 128:17-22. 2004
    ....
  15. ncbi American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
    Debbie Saslow
    Cancer Control Science Department, American Cancer Society, Altanta, GA, USA
    CA Cancer J Clin 57:7-28. 2007
    ..They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed...
  16. ncbi Modulation of novel DNA adducts during human uterine cervix cancer progression
    Srivani Ravoori
    James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202, USA
    Int J Oncol 29:1437-43. 2006
    ..Our data suggest that inflammation may be involved in directing the course of disease progression by accumulating higher levels of DNA lesions. The data further suggest the biomarker potential of the newly detected array of DNA adducts...
  17. ncbi Endometrial cells in cervical cytology: review of cytological features and clinical assessment
    David L Greenspan
    Department of Obstetrics and Gynecology, Maricopa Medical Center, Affiliate of The University of Arizona College of Medicine, Phoenix, 85008, USA
    J Low Genit Tract Dis 10:111-22. 2006
    ..Atypical endometrial cells are associated with a higher rate of significant pathology and should lead to additional evaluation. Additional prospective studies on the management of patients with endometrial cells on Pap tests are needed...
  18. ncbi Advocating for patient preference in cervical cytology screening
    Diane D Davey
    Am J Clin Pathol 117:517-9. 2002
  19. ncbi Misinterpretation of normal cellular elements in fine-needle aspiration biopsy specimens: observations from the College of American Pathologists Interlaboratory Comparison Program in Non-Gynecologic Cytopathology
    Nancy A Young
    Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Arch Pathol Lab Med 126:670-5. 2002
    ..Data generated from this program allow tracking pathologist performance in a wide variety of laboratory practices...
  20. ncbi Bethesda 2001: Science, technology, and democracy join forces for patient care
    Diane D Davey
    Diagn Cytopathol 26:135-6. 2002